David H Fitchett (David Fitchett)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 5

Top Topics

Cardiovascular Disease

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Muthiah Vaduganathan, Catherine M Viscoli, Naveed Sattar, David H Fitchett, Anne Pernille Ofstad, Martina Brueckmann, Jyothis T George, Subodh Verma, Michaela Mattheus, Christoph Wanner, Bernard Zinman, Javed Butler
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial. Diabetes, obesity & metabolism 23 (12) (2021)
Subodh Verma, Abhinav Sharma, Bernard Zinman, Anne Pernille Ofstad, David H Fitchett, Martina Brueckmann, Christoph Wanner, Isabella Zwiener, Jyothis T George, Silvio E Inzucchi, Javed Butler, C David Mazer
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial. Diabetes, obesity & metabolism 22 (7) (2020)
David H Fitchett
A safety update on sodium glucose co-transporter 2 inhibitors. Diabetes, obesity & metabolism (2020)
Subodh Verma, Qiuhe Ji, Deepak L Bhatt, C David Mazer, Mohammed Al-Omran, Silvio E Inzucchi, Christoph Wanner, Anne Pernille Ofstad, Isabella Zwiener, Jyothis T George, Bernard Zinman, David H Fitchett
Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA-REG OUTCOME. Diabetes, obesity & metabolism 22 (7) (2020)
Ruth L Coleman, Alastair M Gray, Uli C Broedl Md, David H Fitchett, Jyothis T George, Hans J Woerle, Bernard Zinman, Rury R Holman
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels? Diabetes, obesity & metabolism 22 (7) (2020)